Ceribell Inc Dossier
Outlook & Key Dates
Estimates, guidance, catalysts, and upcoming events
Analyst Estimates Learn more →
5-Yr Fwd EPS Growth
4.4%projected annual EPS growth
Analyst Coverage
7analysts covering
FY Revenue (est.)
$114Mnext fiscal year
FY EPS (est.)
-$1.68next fiscal year
Monitoring Framework
Key Performance Indicators
Total Revenue Annually89.1MTarget: 112000000 to 116000000
Number of Adopted Hospitals Quarterly600
Gross Profit Margin Quarterly88.0%
Watch Items
- Commercial strategy execution targeting larger regional hospital systems with System Account ManagersTrigger: New account additions and regional system contract winsAction: Monitor quarterly account additions and sales team productivity metrics
- Product launches and clinical adoption for neonate, pediatric, and delirium applicationsTrigger: Revenue contribution starting in late 2026 and scaling into 2027Action: Track regulatory milestones, clinical pilot feedback, and early sales pipeline development
Research as of 19 Jun 2026